U.S. Congress legislation · 119th Congress
SB3788: CLEAR LABELS Act
Status: In committee, July 27, 2026
A bill to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
What the bill says
To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
From the introduced text, July 27, 2026:
A BILL To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. SECTION 1. Short title This Act may be cited as the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act or the CLEAR LABELS Act . SECTION 2. Require drug labeling to include original manufacturer and supply chain information Section 502(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352(b) ) is amended-- (1) by striking containing (1) the name and place of business of the manufacturer, packer, or distributor and inserting the (2) in clause (A) (as so designated), by striking (2) an accurate and inserting the (3) in clause (B) (as so designated), by striking (4) by striking (b) If in a package form and inserting the following: (b) (1) If it is a finished drug product in a package form ; and (5) by adding at the end the following: (2) If it is an active pharmaceutical ingredient, unless any accompanying label and certificate of analysis contains the name, place of business, and unique facility identifier of the original manufacturer. (3) (A) If it is a finished drug product, unless its labeling contains the name, place of business, and unique facility identifier of-- (i) the original …
Sponsors
- Scott, Rick (R) · primary sponsor
- Gillibrand, Kirsten (D)
- Tuberville, Tommy (R)
- Katie Boyd Britt (R, SD-AL)
- Johnson, Ron (R)
- Moody, Ashley (R)
- Lee, Mike (R)
- Cramer, Kevin (R)
- Risch, James (R)
- Grassley, Chuck (R, SD-IA)
- Ricketts, Pete (R)
- Ernst, Joni (R)
Latest actions
- : Placed on Senate Legislative Calendar under General Orders. Calendar No. 523.
- : Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
- : Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
- : Committee on Health, Education, Labor, and Pensions. Hearings held.
- : Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- : Introduced in Senate
Subjects: Consumer affairs, Manufacturing, Health, Prescription drugs, Supply chain
Common questions
- What is SB3788?
- SB3788 is a bill in Congress (119th Congress): CLEAR LABELS Act.
- What does SB3788 do?
- In its own words: To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
- What is the status of SB3788?
- In committee as of July 27, 2026. Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 523. (July 27, 2026).
- Who sponsored SB3788?
- Scott, Rick (R), with 11 co-sponsors.
- Where is the official record for SB3788?
- On the Congress website: https://www.congress.gov/bill/119th-congress/senate-bill/3788
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.